According to new data from the ongoing COMMENCE clinical trial, patients showed no signs of structural valve deterioration after five years.

Researchers noted that these patients received care in the same hospitals and were treated by the same physicians. So why the difference in outcomes? 

Specialists from the American College of Cardiology and Society of Thoracic Surgeons explored data from more than 276,000 patients who have undergone a TAVR procedure in the last nine years. 

The noninvasive technique shows potential where cardiac magnetic resonance imaging falls short.

With the disease becoming more and more common in the United States, researchers have been hard at work determining the best possible treatment options.

Heart and lung surgeons are as satisfied with their jobs as ever, according to new survey results published in The Annals of Thoracic Surgery.

An analysis of PARTNER 2 data published in the New England Journal of Medicine Jan. 29 suggests five-year post-op outcomes are similar among heart patients who undergo either transcatheter or surgical aortic valve replacement.

Nearly 93% of the U.S. population lives in a hospital referral region with at least one medical center that performs 25 or more mitral valve repairs or replacements each year, according to work published in JAMA Cardiology—but MVRR centers continue to suffer from significant geographical and patient-level disparities.